John W Smither's Net Worth
$7.91 Million
Who is John W Smither?
John W Smither has an estimated net worth of $7.91 Million. This is based on reported shares across multiple companies, which include KYTHERA BIOPHARMACEUTICALS INC, Arcutis Biotherapeutics, Inc., Applied Molecular Transport Inc., eFFECTOR Therapeutics, Inc., Principia Biopharma Inc., Sienna Biopharmaceuticals, Inc., Achaogen Inc, and GENELUX Corp.
SEC CIK
John W Smither's CIK is 0001559583
Past Insider Trading and Trends
2014 was John W Smither's most active year for acquiring shares with 17 total transactions. John W Smither's most active month to acquire stocks was the month of December. 2015 was John W Smither's most active year for disposing of shares, totalling 38 transactions. John W Smither's most active month to dispose stocks was the month of August. 2015 saw John W Smither paying a total of $1,582,798.88 for 182,219 shares, this is the most they've acquired in one year. In 2015 John W Smither cashed out on 283,526 shares for a total of $5,839,214.88, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
KYTHERA BIOPHARMACEUTICALS INC No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -24.18K |
—
|
—
|
0
|
Oct 1
| |||
Form 4
| +416.18% | 14.02K |
$4.84 | $67,842.28 | 17.39K |
Sep 25
| |||
Form 4
|
—
|
0
|
$50.94 | -$2,580,298.40 | 3.37K |
Sep 23 - Sep 24
| |||
Form 4
| -12.75% | -1.40K |
$41.57 | -$443,141.30 | 9.58K |
Jun 26 - Sep 22
| |||
Form 4/A
|
∞
| 3.37K |
$45.49 | -$92,845.09 | 3.37K |
Apr 29 - Apr 30
| |||
Form 4/A
| -37.66% | -4.60K |
$75.50 | -$347,300.00 | 7.62K |
Jun 25
| |||
Form 4
| -29.52% | -4.60K |
$75.50 | -$347,300.00 | 10.98K |
Jun 25
| |||
Form 4
| +27.57% | 3.37K |
$45.49 | -$92,845.09 | 15.58K |
Apr 29 - Apr 30
| |||
Form 4
| -25.58% | -4.20K |
$48.09 | -$201,980.00 | 12.22K |
Scheduled
|
Mar 5
| ||
Form 4
| -10.86% | -2.00K |
$41.00 | -$82,000.00 | 16.42K |
Scheduled
|
Feb 17 - Feb 18
| ||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
| -5.15% | -1.00K |
$38.00 | -$38,000.00 | 18.42K |
Scheduled
|
Jan 29
| ||
Form 4
| -56.69% | -25.42K |
$35.65 | -$106,940.00 | 19.42K |
Scheduled
|
Sep 20 - Jan 23
| ||
Form 4
| +38.37% | 6.22K |
$1.35 | $8,391.60 | 22.42K |
Jan 5
| |||
Form 4
|
—
|
0
|
$21.86 | -$10,226.25 | 16.2K |
Scheduled
|
Dec 22
| ||
Form 4
|
—
|
0
|
$21.53 | -$9,978.75 | 16.2K |
Scheduled
|
Nov 20
| ||
Form 4
|
—
|
0
|
$20.38 | -$9,116.25 | 16.2K |
Scheduled
|
Oct 20
| ||
Form 4
|
—
|
0
|
$21.92 | -$10,271.25 | 16.2K |
Scheduled
|
Sep 22
| ||
Form 4
|
—
|
0
|
$21.63 | -$10,057.50 | 16.2K |
Scheduled
|
Aug 20
| ||
Form 4
|
—
|
0
|
$20.81 | -$9,442.50 | 16.2K |
Scheduled
|
Jul 21
| ||
Form 4
|
—
|
0
|
$24.11 | -$71,505.00 | 16.2K |
Scheduled
|
Jul 2
| ||
Form 4
|
—
|
0
|
$23.14 | -$11,190.00 | 16.2K |
Scheduled
|
Jun 20
| ||
Form 4
| +22.73% | 3K |
$4.84 | $14,520.00 | 16.2K |
Jun 13
| |||
Form 4
|
—
|
0
|
$19.05 | -$9,862.72 | 13.2K |
Scheduled
|
May 20
| ||
Form 4
|
—
|
0
|
$21.01 | -$11,332.50 | 13.2K |
Scheduled
|
Apr 21
| ||
Form 4
| +29.41% | 3K |
$1.35 | $4,050.00 | 13.2K |
Mar 26
| |||
Form 4
|
—
|
0
|
$24.84 | -$42,615.79 | 10.2K |
Scheduled
|
Mar 20
| ||
Form 4
|
—
|
0
|
$27.83 | -$98,651.25 | 10.2K |
Scheduled
|
Feb 20
| ||
Form 4
|
—
|
0
|
$27.95 | -$49,612.50 | 10.2K |
Scheduled
|
Feb 14
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 4
|
—
|
0
|
$24.22 | -$41,218.54 | 10.2K |
Scheduled
|
Jan 21
| ||
Form 4
| +13.33% | 1.2K |
$1.35 | $1,620.00 | 10.2K |
Dec 16
| |||
Form 4
|
∞
| 9K |
$1.35 | $12,150.00 | 9K |
Nov 6
| |||
Form 4
|
—
|
0
|
$15.69 | -$1,146,996.00 |
0
|
Scheduled
|
Sep 9 - Sep 10
| ||
Form 4
|
—
|
0
|
$14.08 | -$254,505.00 |
0
|
Scheduled
|
Aug 1
| ||
Form 4
|
—
|
0
|
$13.68 | -$147,900.00 |
0
|
Scheduled
|
Jun 17
| ||
Form 4
|
—
|
0
|
$12.73 | -$91,029.20 |
0
|
Scheduled
|
May 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Arcutis Biotherapeutics, Inc. (ARQT) Snapshot price: $5.73
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 11.37K |
—
|
—
| 11.37K |
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -0.93% | -1.25K |
$17.29 | -$56,734.70 | 133.04K |
Scheduled
|
Mar 10
| ||
Form 4
| +89.65% | 21.9K |
$1.68 | $20,832.72 | 46.32K |
Mar 3 - Mar 4
| |||
Form 4
| -3.07% | -773.00 |
$34.20 | -$26,439.69 | 24.43K |
Scheduled
|
Mar 1
| ||
Form 4
| -1.74% | -2.00K |
$18.66 | -$96,749.55 | 113.16K |
Scheduled
|
Feb 10
| ||
Form 4
| -3.15% | -3.75K |
$18.34 | -$172,899.25 | 115.16K |
Scheduled
|
Feb 1
| ||
Form 4
| -1.04% | -1.25K |
$15.84 | -$51,659.70 | 118.91K |
Scheduled
|
Jan 19
| ||
Form 4
| -3.03% | -3.75K |
$15.84 | -$154,979.10 | 120.16K |
Scheduled
|
Dec 14
| ||
Form 4
| -1.01% | -1.25K |
$15.84 | -$51,659.70 | 122.59K |
Scheduled
|
Sep 29
| ||
Form 4
| +13.65% | 14.88K |
$1.68 | $24,998.93 | 123.84K |
Jun 11
| |||
Form 4
| +9.00% | 9K |
—
|
—
| 108.97K |
Feb 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Applied Molecular Transport Inc. (AMTI) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24 - Dec 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
eFFECTOR Therapeutics, Inc. (EFTR) Snapshot price: $10.19
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 6
| |||
Form 4
|
∞
| 24.14K |
—
|
—
| 24.14K |
Aug 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Principia Biopharma Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||